H1B Report
H-1B sponsorMAFEIN 01-0852078Updated Jul 2026

Genzyme Therapeutic Products Limited Partnership

US H-1B Labor Condition Application activity for Genzyme Therapeutic Products Limited Partnership. Filed 124 disclosures between FY2013 and FY2025 from worksites with a MA headquarters indicator.

Total filings
6
Outside top-N · FY2025
Certified
100.0%
unconditional · FY2025
Withdrawn
0.0%
withdrawn rate · FY2025
Denied
0.0%
rejection rate · FY2025

H-1B outcome breakdown

Share of Genzyme Therapeutic Products Limited Partnership’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 81.5%, Cert-withdrawn 16.1%, Withdrawn 0.8%, Denied 1.6%
Outcome breakdown
OutcomeShare
Certified81.5%
Cert-withdrawn16.1%
Withdrawn0.8%
Denied1.6%
Certified81.5%
Cert-withdrawn16.1%
Withdrawn0.8%
Denied1.6%

Top occupations sponsored

SOC codes filed most by Genzyme Therapeutic Products Limited Partnership across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201311
FY201435
FY201516
FY201612
FY201724
FY20186
FY20198
FY20201
FY20212
FY20243
FY20256
Time series: 11 points from FY2013 to FY2025
Time series
PeriodValue
FY201311
FY201435
FY201516
FY201612
FY201724
FY20186
FY20198
FY20201
FY20212
FY20243
FY20256
Compare Genzyme Therapeutic Products Limited Partnership with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.